Hyperhomocysteinemia: An Overlooked Risk Factor. New Clinical Insights and Treatment Strategies

Elevated homocysteine levels are a silent but significant risk factor for cardiovascular disease, neurodegeneration, and pregnancy complications — and they are far more common than we think.

🔬 The recent study “Hyperhomocysteinemia in an Unselected Female Population”, published in the Journal of Medicinal Food, shows that over 80% of women evaluated had homocysteine levels above 10 μmol/L, despite not presenting specific clinical conditions.

📉 After 2 months of supplementation with Eucis Plus, a 36% average reduction in homocysteine levels was observed — with excellent tolerability and no significant side effects.

🧪 Thanks to its targeted formula (active folate, betaine, and B vitamins), Eucis Plus supports homocysteine metabolism even in individuals with MTHFR gene variants, where standard folic acid may not be effective.

👉 Download the full document to explore the study’s findings and their clinical relevance.